---
title: Diagnosis, management and treatment of the Alport syndrome - 2024 guideline
  on behalf of ERKNet, ERA and ESPN
date: '2024-12-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39673454/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241215171557&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Glomerular nephropathy resulting from the genetic defects in COL4A3/4/5
  genes including the classical Alport syndrome (AS) is the second commonest hereditary
  kidney disease characterized by persistent haematuria progressing to the need of
  kidney replacement therapy, frequently associated with sensorineural deafness, and
  occasionally with ocular anomalies. Diagnosis and management of COL4A3/4/5 glomerulopathy
  is a great challenge due to its phenotypic heterogeneity, multiple modes of ...
disable_comments: true
---
Glomerular nephropathy resulting from the genetic defects in COL4A3/4/5 genes including the classical Alport syndrome (AS) is the second commonest hereditary kidney disease characterized by persistent haematuria progressing to the need of kidney replacement therapy, frequently associated with sensorineural deafness, and occasionally with ocular anomalies. Diagnosis and management of COL4A3/4/5 glomerulopathy is a great challenge due to its phenotypic heterogeneity, multiple modes of ...